Kaliumiodid Lannacher

Potassium Iodide, the active ingredient in Kaliumiodid Lannacher, is an iodine compound presented as an oral preparation for oral use. It is employed to protect the thyroid gland from radioactive iodine exposure and to prevent iodine deficiency in individuals at risk.

GNH USA supplies Kaliumiodid Lannacher as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kaliumiodid Lannacher provides iodide for thyroid‑related protection and deficiency prevention.

- Protection of the thyroid gland from radioactive iodine exposure: blocks uptake of radioactive iodine by the thyroid. - Prevention of iodine deficiency: supplies essential iodide for normal thyroid hormone synthesis. - Thyroid prophylaxis in emergency preparedness: used as a stockpiled measure for populations at risk of nuclear incidents.

Adverse reactions may occur with oral potassium iodide administration.

Common Side Effects: - Nausea or upset stomach: mild gastrointestinal discomfort after ingestion. - Metallic taste: transient alteration of taste perception. - Headache: mild to moderate headache reported by some users. - Mild skin rash: occasional erythematous skin irritation. - Increased salivation: temporary excess saliva production.

Serious or Rare Side Effects: - Allergic reaction: hives, swelling, or anaphylaxis requiring immediate medical attention. - Thyrotoxicosis: excessive thyroid hormone release in susceptible individuals. - Hypothyroidism: reduced thyroid function after prolonged use. - Severe abdominal pain: persistent or worsening gastrointestinal pain. - Pulmonary edema: rare fluid accumulation in lungs, especially in patients with pre‑existing heart disease.

When considering potassium iodide therapy, several safety measures should be observed.

- Assess iodine status: evaluate baseline iodine levels before initiating therapy. - Avoid in known iodine allergy: contraindicated for patients with hypersensitivity to iodide. - Use under medical supervision: administration should be directed by a qualified healthcare professional. - Monitor thyroid function: periodic testing recommended during prolonged use. - Adjust in renal impairment: consider dose modification for patients with reduced kidney function. - Store below 25°C: keep in the original pack, protect from moisture.

Potassium iodide may interact with other medications that affect thyroid function or iodine metabolism.

Major Interactions (Avoid): - Radioactive iodine therapy: concurrent use reduces therapeutic efficacy of radioactive iodine. - Lithium: may exacerbate lithium‑induced thyroid dysfunction. - Amiodarone: additive iodine load can precipitate thyroid disorders.

Moderate Interactions (Monitor Closely): - Antithyroid drugs (e.g., methimazole, propylthiouracil): may diminish the protective effect of potassium iodide. - ACE inhibitors: monitor for altered renal handling of iodide. - Diuretics: may affect potassium balance, requiring electrolyte monitoring.